Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Atherosclerosis I: Introduction01:30

Atherosclerosis I: Introduction

2.5K
Atherosclerosis is a progressive disorder characterized by the buildup of plaques on the arterial inner wall, causing them to narrow and harden over time. These plaques comprise lipids, calcium, blood components, carbohydrates, and fibrous tissue. The process primarily affects the intima of large and medium-sized arteries, reducing blood flow in any artery.Etiology and risk factorsThe cause of atherosclerosis is multifactorial, involving a complex interplay among endothelial injury, lipid...
2.5K
Inflammation01:38

Inflammation

46.8K
Overview
46.8K
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

1.1K
Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
1.1K
Peripheral Artery Disease I: Introduction01:30

Peripheral Artery Disease I: Introduction

663
Peripheral artery disease (PAD) predominantly results from atherosclerosis, which involves the accumulation of fatty deposits, or plaques, within the walls of arteries. This causes them to narrow and harden, significantly reducing blood flow. PAD predominantly affects the legs, particularly the arteries supplying the thighs and calves. In rare cases, it may involve other arteries, including those in the arms.Etiology of PAD:The principal cause of PAD is atherosclerosis, which results from fatty...
663
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

1.8K
Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
1.8K
Atherosclerosis II: Clinical Manifestations and Diagnostic Tests01:27

Atherosclerosis II: Clinical Manifestations and Diagnostic Tests

961
Atherosclerosis is a progressive disorder that leads to the thickening and narrowing of arterial walls due to plaque buildup. This condition can cause various symptoms depending on the arteries affected:Coronary Artery Disease (CAD): This condition affects the coronary arteries and may lead to chest pain (angina), shortness of breath (dyspnea), heart attacks, and other heart disease symptoms.Cerebrovascular Disease: This affects blood flow to the brain, causing transient ischemic attacks (TIAs)...
961

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

MORF4L1 regulation and its role in chromatin remodeling, DNA damage, cellular senescence, and cardiometabolic disease.

Vascular pharmacology·2026
Same author

HDL Regulates TGFβ-Receptor Lipid Raft Partitioning, Restoring Contractile Features of Cholesterol-Loaded Vascular Smooth Muscle Cells.

JACC. Basic to translational science·2026
Same author

MTEGDRP: Interpretable Molecular Self-Attention Transformer and Equivariant Graph Neural Network Based on Multi-Omics Fusion for Drug Response Prediction in Cancer Cell Lines.

Journal of medicinal chemistry·2026
Same author

A Road Map to Understanding Cardiovascular Disease in Diabetes: From the AHA Strategically Focused Research Network in Cardiometabolic Health and Type 2 Diabetes.

Circulation research·2026
Same author

The <i>Non-Coding RNA</i> Journal Club: Highlights on Recent Papers-14.

Non-coding RNA·2025
Same author

Flipping the PRDM16 switch in 'multifunctional mesenchymes' may help to define atherosclerotic plaque.

Nature cardiovascular research·2025

Related Experiment Video

Updated: May 6, 2026

Using En Face Immunofluorescence Staining to Observe Vascular Endothelial Cells Directly
06:09

Using En Face Immunofluorescence Staining to Observe Vascular Endothelial Cells Directly

Published on: August 20, 2019

15.7K

Endothelial microRNAs and atherosclerosis.

Xinghui Sun1, Nathan Belkin, Mark W Feinberg

  • 1Department of Medicine, Cardiovascular Division, Brigham and Women's Hospital, Harvard Medical School, 77 Avenue Louis Pasteur, NRB-742F, Boston, MA, 02115, USA.

Current Atherosclerosis Reports
|October 26, 2013
PubMed
Summary

MicroRNAs (miRNAs) regulate endothelial cell function and vascular inflammation. Understanding these microRNAs offers new therapeutic targets for atherosclerosis and chronic inflammatory diseases.

More Related Videos

A Human Ex Vivo Atherosclerotic Plaque Model to Study Lesion Biology
05:51

A Human Ex Vivo Atherosclerotic Plaque Model to Study Lesion Biology

Published on: May 6, 2014

13.0K
Single Nuclei Isolation from Coronary Endarterectomy Tissue of Coronary Artery Bypass Graft Patients
09:09

Single Nuclei Isolation from Coronary Endarterectomy Tissue of Coronary Artery Bypass Graft Patients

Published on: April 3, 2026

274

Related Experiment Videos

Last Updated: May 6, 2026

Using En Face Immunofluorescence Staining to Observe Vascular Endothelial Cells Directly
06:09

Using En Face Immunofluorescence Staining to Observe Vascular Endothelial Cells Directly

Published on: August 20, 2019

15.7K
A Human Ex Vivo Atherosclerotic Plaque Model to Study Lesion Biology
05:51

A Human Ex Vivo Atherosclerotic Plaque Model to Study Lesion Biology

Published on: May 6, 2014

13.0K
Single Nuclei Isolation from Coronary Endarterectomy Tissue of Coronary Artery Bypass Graft Patients
09:09

Single Nuclei Isolation from Coronary Endarterectomy Tissue of Coronary Artery Bypass Graft Patients

Published on: April 3, 2026

274

Area of Science:

  • Vascular biology and molecular medicine.
  • Endothelial cell (EC) function and dysfunction.
  • MicroRNA (miRNA) regulation in cardiovascular disease.

Background:

  • The vascular endothelium is a critical interface regulating tissue homeostasis.
  • Endothelial dysfunction and vascular inflammation are implicated in atherosclerosis.
  • Nuclear factor kappa B (NF-κB) signaling is a key pathway in EC activation.

Purpose of the Study:

  • To review the role of microRNAs (miRNAs) in regulating endothelial cell function.
  • To discuss how miRNAs modulate vascular inflammation in response to pathophysiologic stimuli.
  • To highlight the therapeutic potential of miRNAs in atherosclerosis and inflammatory diseases.

Main Methods:

  • Literature review of studies on miRNAs, endothelial cells, and vascular inflammation.
  • Analysis of signaling pathways involved in EC activation and dysfunction.
  • Synthesis of current knowledge on miRNA regulation of gene expression in the endothelium.

Main Results:

  • MicroRNAs (miRNAs) are key regulators of endothelial cell (EC) function.
  • miRNAs fine-tune gene expression in response to various insults like cytokines and oxidative stress.
  • Dysregulated miRNA expression contributes to EC activation and vascular inflammation.

Conclusions:

  • MicroRNAs play a significant role in endothelial cell function and vascular inflammation.
  • Targeting miRNAs presents novel therapeutic strategies for atherosclerosis.
  • Further understanding of miRNA mechanisms can lead to treatments for chronic inflammatory diseases.